Holen Sie sich die Stockscreener-App
10.38
0.29%
0.03
Handel nachbörslich:
10.38
Jena Acquisition Corp Ii Aktie (JENA) Neueste Nachrichten
Jena Acquisition (NYSE: JENA) logs Q1 trust income, faces NYSE holder shortfall - Stock Titan
News Corporation Announces Share Buyback Program to Enhance Shareholder Value – Details for Class A and B Securities 81424 - Minichart
TradingKey - TradingKey
Cannae Holdings (NYSE: CNNE) cuts external fees, refocuses on sports assets - Stock Titan
Jena Acquisition Corporation II (JENA.R) Stock PDF (Updated: 2026/04/27) - GuruFocus
SPAC Jena Acquisition Corp II sets $200M IPO terms - MSN
symbol__ Stock Quote Price and Forecast - CNN
Jena Acquisition flagged by NYSE over shareholder requirement - MSN
Is Jena (JENA) stock losing technical support | JENA Latest Quarter Earnings: Jena posts no revenue as it seeks de-SPAC targetsRevenue Breakdown - Xã Thanh Hà
T1 Energy Inc. Announces $160 Million Offering of 4.00% Convertible Senior Notes Due 2031 – Underwriting Agreement Details and SEC Filing - Minichart
JENA Ownership | JENA ACQUISITION CORP IIA (NYSE:JENA) - ChartMill
Roku, Inc. Announces Segment Split Into Advertising and Subscriptions with Supplemental Financials for 2024-2025 - Minichart
Aehr Test Systems Reports Over $37 Million in Quarterly Bookings and Strong AI, Data Center Demand in Q3 Fiscal 2026 Financial Results - Minichart
Advanced Biomed Inc. to Acquire Acellent Technologies (Hong Kong) in $1.08 Million All-Stock Deal - Minichart
Jena Acquisition Corporation II Receives NYSE Non-Compliance Notice for Minimum Shareholders, Plans De-SPAC Solution - Minichart
H2 Water Technologies Ltd. Announces Issuance of Key U.S. Patent for Producing Hydrogen Rich Water; Identifies Echo Water's 'Hydrogen Prebiotic Stick” as Infringing Product - The Manila Times
ColonBroom Claims Evaluated: Latest Research Reviews Must-Know Colon Broom Fiber Supplementation Facts - The Manila Times
Overcoming Onychomycosis Claims Evaluated: Blue Heron Health News Nail Fungus Treatment Program is On Sale - The Manila Times
Crypto News: AlphaPepe Stage 10 Nearly Sold Out Prior Big Price Rise As XRP Eyes $5 Breakout - The Manila Times
Jena Acquisition Corporation II Announces Non-Compliance with Section 802.01B of the NYSE Listed Company Manual which Requires the Company to Maintain a Minimum of 300 Public Stockholders - Weekly Voice
Jena Acquisition II Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards - The Manila Times
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
NYSE flags Jena Acquisition (NYSE: JENA) for falling below 300 public holders - Stock Titan
Jena Acquisition Corporation II Announces Non-Compliance with Section 802.01B of the NYSE ... - Enidnews.com
NYSE says Jena SPAC fell below 300 public stockholders - Stock Titan
USA Stocks: Research Stocks from USA Stock Market - GuruFocus
Stock List: Research Stocks from Around the World - GuruFocus
Jena Acquisition Corporation II: Valuation Ratios, Analysts' Forecasts - marketscreener.com
Comms expert Shipra Jena co-launches platform to fuel growth for 1,000+ women-owned brands - prmoment.in
JenaValve begins commercial rollout of Trilogy heart valve in US - MassDevice
SVAQ PE Ratio & Valuation, Is SVAQ Overvalued - Intellectia AI
Jena Acquisition Corporation II Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Jena Acquisition Corporation II 2025 Annual Report: Business Strategy, Acquisition Criteria, and SPAC Operations Overview - Minichart
Jena Acquisition II 10-K: $0 Revenue, $1.84M Net Loss - TradingView
Jena Acquisition Corporation (NYSE: JENA) outlines SPAC trust cash, deadline and dilution terms - Stock Titan
SEC Filings for Mar 27, 202610-K, 10-Q, 8-K Forms - Stock Titan
JenaValve wins FDA nod for Trilogy heart valve system - MassDevice
Campbell Soup Company Q2 2026 Financial Results: Earnings, Revenue, and Key Highlights - Minichart
TAVR valve for AR , a recent Edwards acquisition, delivers long-term value - Cardiovascular Business
FTC Win Clarifies Antitrust Enforcement in Development Pipeline Deals - Arnold & Porter
Is Jena Acquisition Corporation II Units stock worth buying before Fed action - mfd.ru
Court Halts Edwards’ $945M JenaValve Buy - Orange County Business Journal
Edwards scraps Jenavalve buy in face of FTC objections - BioWorld MedTech
FTC wins case blocking Edwards' $945M JenaValve takeover - Fierce Biotech
Published on: 2026-01-11 00:38:45 - ulpravda.ru
Edwards gives up on $1.2B JenaValve acquisition - MassDevice
US court blocks heart valve deal; Edwards boosts outlook, backs therapy - Stock Titan
Court sides with FTC to put Edwards Lifesciences’ JenaValve acquisition on hold - MassDevice
P 500 performance this yearModel Comparison & how to pick the right width - ulpravda.ru
Market Moves: How Jena Acquisition Corporation II Rights stock reacts to stronger dollarJuly 2025 PreEarnings & Expert Approved Trade Ideas - ulpravda.ru
3.97%
0.20%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):